Klinik Araştırma

Evaluation of NLRP3 and Asprosin Levels in Hashimoto's Thyroiditis

Cilt: 36 Sayı: 2026 19 Haziran 2026
PDF İndir
EN TR

Evaluation of NLRP3 and Asprosin Levels in Hashimoto's Thyroiditis

Öz

Aim: The aim of the study is to evaluate how NOD-like receptor pyrin domain-containing 3 (NLRP3)  and asprosin change in Hashimoto’s thyroiditis ( HT), one of the autoimmune thyroid diseases.
Materials and Methods: A total of 88 people, 48 patients with a diagnosis of HT and 40 healthy volunteers who applied to the Internal Medicine and Endocrinology Polyclinics between May 2019 and September 2020, were included in the study. All data recorded in the study were evaluated using the SPSS 22.0 program.
Results: There were 41 (85.0%) women and 7 (15.0%) men in the HT group, with a mean age of 31.06±5.76 years. In the control group, there were 30 (75.0%) women and 10 (25.0%) men, and their mean age was 29.47±6.31 years. Asprosin level was found to be higher in the patient group than in the control group (52.74±25.31, 34.61±13.84, p<0.001, respectively). Likewise, NLRP3 levels were higher in the patient group (227.84±107.27) than in the control group (145.94±54.83, respectively, p<0.001). A significant positive correlation was found between NLRP3 and asprosin (r:0.443 p<0.001) and CRP (r:0.361 p<0.001).
Conclusions: It has been observed that NLRP3 and asprosin levels may influence glucose metabolism and inflammatory processes in patients with HT, and there is a need for more comprehensive studies that could improve diagnosis, follow-up, and treatment.

Anahtar Kelimeler

Hashimoto, autoimmune thyroid diseases, NLRP3, asprosin, inflammatory processes

Kaynakça

  1. 1. Mincer DL, Jialal I. Hashimoto Thyroiditis. 2022 Jun 21. In: StatPearls . Treasure Island (FL): StatPearls Publishing;2022 Jan.
  2. 2. Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457-1464.
  3. 3. Zhang Y, Yang W, Li W, Zhao Y. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases. Front Immunol 2021;12:732933.
  4. 4. Zhen Y, Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Front Immunol. 2019;10:276.
  5. 5. Li Z, Guo J, Bi L. Role of the NLRP3 inflammasome in autoimmune diseases. Biomed Pharmacother. 2020;130:110542.
  6. 6. Zhao S, Li X, Wang J, Wang H. The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases. Front Cell Dev Biol. 2021;9:657478.
  7. 7. Eom YS, Wilson JR, Bernet VJ. Links between Thyroid Disorders and Glucose Homeostasis. Diabetes Metab J. 2022;46(2):239-256.
  8. 8. Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40(3):789-824.
  9. 9. Baranowska-Bik A, Bik W. The Association of Obesity with Autoimmune Thyroiditis and Thyroid Function-Possible Mechanisms of Bilateral Interaction. Int J Endocrinol. 2020;2020:8894792.
  10. 10. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-7.

Kaynak Göster

APA
Gökçe, A., & Cindoğlu, Ç. (2026). Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis. Genel Tıp Dergisi, 36(2026), 1-4. https://doi.org/10.54005/geneltip.1761055
AMA
1.Gökçe A, Cindoğlu Ç. Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis. Genel Tıp Derg. 2026;36(2026):1-4. doi:10.54005/geneltip.1761055
Chicago
Gökçe, Ali, ve Çiğdem Cindoğlu. 2026. “Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis”. Genel Tıp Dergisi 36 (2026): 1-4. https://doi.org/10.54005/geneltip.1761055.
EndNote
Gökçe A, Cindoğlu Ç (01 Haziran 2026) Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis. Genel Tıp Dergisi 36 2026 1–4.
IEEE
[1]A. Gökçe ve Ç. Cindoğlu, “Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis”, Genel Tıp Derg, c. 36, sy 2026, ss. 1–4, Haz. 2026, doi: 10.54005/geneltip.1761055.
ISNAD
Gökçe, Ali - Cindoğlu, Çiğdem. “Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis”. Genel Tıp Dergisi 36/2026 (01 Haziran 2026): 1-4. https://doi.org/10.54005/geneltip.1761055.
JAMA
1.Gökçe A, Cindoğlu Ç. Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis. Genel Tıp Derg. 2026;36:1–4.
MLA
Gökçe, Ali, ve Çiğdem Cindoğlu. “Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis”. Genel Tıp Dergisi, c. 36, sy 2026, Haziran 2026, ss. 1-4, doi:10.54005/geneltip.1761055.
Vancouver
1.Ali Gökçe, Çiğdem Cindoğlu. Evaluation of NLRP3 and Asprosin Levels in Hashimoto’s Thyroiditis. Genel Tıp Derg. 01 Haziran 2026;36(2026):1-4. doi:10.54005/geneltip.1761055